ES2410205T3 - Composición antidiabética que contiene ácido chicórico y/o uno de sus metabolitos - Google Patents

Composición antidiabética que contiene ácido chicórico y/o uno de sus metabolitos Download PDF

Info

Publication number
ES2410205T3
ES2410205T3 ES07802689T ES07802689T ES2410205T3 ES 2410205 T3 ES2410205 T3 ES 2410205T3 ES 07802689 T ES07802689 T ES 07802689T ES 07802689 T ES07802689 T ES 07802689T ES 2410205 T3 ES2410205 T3 ES 2410205T3
Authority
ES
Spain
Prior art keywords
insulin
composition
chicoric acid
acid
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07802689T
Other languages
English (en)
Spanish (es)
Inventor
Claude Andary
Gérard Ribes
Didier Tousch
Jacqueline Azay-Milhau
Anne-Dominique Lajoix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2410205T3 publication Critical patent/ES2410205T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
ES07802689T 2006-08-18 2007-08-17 Composición antidiabética que contiene ácido chicórico y/o uno de sus metabolitos Active ES2410205T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0607382A FR2904935A1 (fr) 2006-08-18 2006-08-18 Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
FR0607382 2006-08-18
PCT/EP2007/058580 WO2008022974A2 (fr) 2006-08-18 2007-08-17 Composition antidiabetique contenant de l'acide chicorique et/ou l'un de ses metabolites

Publications (1)

Publication Number Publication Date
ES2410205T3 true ES2410205T3 (es) 2013-07-01

Family

ID=37836752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07802689T Active ES2410205T3 (es) 2006-08-18 2007-08-17 Composición antidiabética que contiene ácido chicórico y/o uno de sus metabolitos

Country Status (7)

Country Link
US (1) US8404746B2 (enExample)
EP (1) EP2056802B1 (enExample)
JP (1) JP5242567B2 (enExample)
CA (1) CA2661329C (enExample)
ES (1) ES2410205T3 (enExample)
FR (1) FR2904935A1 (enExample)
WO (1) WO2008022974A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210504A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising chicoric acid and/or derivatives thereof
EP2210505A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising caftaric acid and/or derivatives thereof
JP2013530995A (ja) * 2010-06-30 2013-08-01 ネステク ソシエテ アノニム 皮膚の色素沈着を調節するための、栄養補助食品におけるチコリ酸及び誘導体の使用
WO2013072522A1 (en) * 2011-11-18 2013-05-23 Dialpha Composition comprising chicory extract
US20140045937A1 (en) * 2012-08-08 2014-02-13 Oculus Innovative Sciences, Inc. Methods of treating polycystic ovarian syndrome using chlorogenic acid
WO2014048888A1 (en) * 2012-09-28 2014-04-03 Nestec S.A. Dihydroferulic acid and/or dihydrocaffeic acid for use in the treatment of metabolic diseases
US20160022752A1 (en) * 2013-03-12 2016-01-28 HMI Medical Innovations, LLC Plant extracts with anti-diabetic and other useful activities
EP2848286A1 (en) * 2013-09-12 2015-03-18 DSM IP Assets B.V. Cosmetic composition comprising chicoric acid
EP3089707B1 (en) * 2013-12-30 2021-06-30 New York Stem Cell Foundation, Inc. Tissue grafts and methods of making and using the same
FR3017510B1 (fr) 2014-02-19 2017-04-21 Inst Nat De La Rech Agronomique - Inra Composition phytosanitaire
US9259410B2 (en) 2014-04-08 2016-02-16 Oculus Innovative Sciences, Inc. Methods of treating polycystic ovarian syndrome using chlorogenic acid and inositol
JP6981685B2 (ja) * 2014-10-21 2021-12-17 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
FR3042411B1 (fr) * 2015-10-20 2019-07-12 Valbiotis Composition comprenant un melange de molecules particulieres et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
DE102015118318B4 (de) 2015-10-27 2018-05-03 Karl Leibinger Medizintechnik Gmbh & Co. Kg Automatisierte Generierung von Knochenbehandlungsmitteln
JP6700029B2 (ja) * 2015-12-04 2020-05-27 国立大学法人神戸大学 糖取り込み促進剤
DE102017206827A1 (de) * 2017-04-24 2018-10-25 Roman Gehre Gewinnung und Nutzung von Polyphenolen, insbesondere Cichoriensäure, aus Pflanzen der Gattung Posidonia

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1949822A1 (de) * 1969-10-02 1971-04-15 Ferdinand Sedlacek Verfahren zur Herstellung eines Mittels zwecks Normalisierung des Blutzuckergehaltes
JPS6140763A (ja) * 1984-08-02 1986-02-27 Osaka Chem Lab 抗肥満食品
JPS61171418A (ja) * 1985-01-23 1986-08-02 Wakunaga Seiyaku Kk 抗糖尿病剤
FR2638967B1 (fr) * 1988-11-17 1993-10-22 Andary Claude Derives de l'acide cafeique pour leur application en tant qu'analgesiques
CN1032403C (zh) * 1992-11-19 1996-07-31 秦元贵 中药奇可力制剂及其制备方法
JP2002524505A (ja) * 1998-09-15 2002-08-06 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー 高血中脂質濃度に因る疾患の予防または治療のための、ケイ皮酸誘導体を含む組成物
GB9903216D0 (en) 1999-02-13 1999-04-07 Zylepsis Ltd Preservative compounds,compositions and methods of making and using the same
US7056539B2 (en) * 1999-03-12 2006-06-06 Vladimir Leko Process and product extracted from herbal composition useful in controlling diabetes mellitus type II
CH694360A5 (de) * 2000-07-21 2004-12-15 Bioforce Ag Extraktion von Wirkstoffen aus Pflanzen.
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
JP2005314435A (ja) * 2000-08-30 2005-11-10 Eijiro Tagashira 循環器疾患治療剤および健康食品
JP4361228B2 (ja) * 2001-01-12 2009-11-11 和歌山県 体重増加抑制剤
FR2820738B1 (fr) * 2001-02-15 2003-05-16 Agronomique Inst Nat Rech Procede d'extraction, de fractionnement et de purification de composes polyphenoliques issus d'ecarts de triage de vegetaux frais utilisant une resine a haut rendement d'adsorption et d'elution
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
JP2003116486A (ja) * 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
FR2830251A1 (fr) * 2001-10-01 2003-04-04 Univ Claude Bernard Lyon Procede de synthese de l'acide chicorique
KR20050073611A (ko) * 2002-11-06 2005-07-14 카오카부시키가이샤 혈액 유동성 개선제
HRP20030816B1 (hr) * 2003-10-10 2012-05-31 Leko Vlado Biljni pripravak u obliku kapsula kao pomoćni lijek za dijabetes mellitus tipa (i) i (ii)
AU2005259864A1 (en) * 2004-06-30 2006-01-12 Combinatorx, Incorporated Methods and reagents for the treatment of metabolic disorders

Also Published As

Publication number Publication date
WO2008022974A2 (fr) 2008-02-28
EP2056802B1 (fr) 2013-03-13
US8404746B2 (en) 2013-03-26
JP2010501023A (ja) 2010-01-14
WO2008022974A3 (fr) 2008-12-04
FR2904935A1 (fr) 2008-02-22
CA2661329C (fr) 2016-01-12
US20110015140A1 (en) 2011-01-20
JP5242567B2 (ja) 2013-07-24
EP2056802A2 (fr) 2009-05-13
CA2661329A1 (fr) 2008-02-28

Similar Documents

Publication Publication Date Title
US8404746B2 (en) Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof
US20210113648A1 (en) Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathy
Atchibri et al. Screening for antidiabetic activity and phytochemical constituents of common bean (Phaseolus vulgaris L.) seeds
WO2019246221A1 (en) Compositions and methods for the treatment of liver diseases and disorders
JPH09176019A (ja) 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
KR20100103538A (ko) 당뇨병성 신장질환용 약제학적 조성물 및 이의 제제 및 적용
Deshmukh et al. Evaluation of in vivo analgesic and anti-inflammatory activity of ethanolic extract of medicinal plant-Lagenaria siceraria
KR101965061B1 (ko) 땅콩 새싹 추출물 또는 이의 분획물을 포함하는 대사성 질환의 예방 또는 치료용 조성물
Kulandaivel et al. Antihyperglycemic activity of Trichosanthes tricuspidata root extract
Gupta et al. Prosopis cineraria and its various therapeutic effects with special reference to diabetes: A novel approach
WO2015063674A1 (en) Herbal composition, process for its preparation and use thereof
JP5671524B2 (ja) 心血管障害の治療用医薬組成物及びその使用
US8318216B2 (en) Ayurvedic formulation advocated for the prevention and management of coronary heart disease
JP6977053B2 (ja) ギ酸またはその薬学的に許容可能な塩を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物
KR101775087B1 (ko) 멀베로푸란 g, 상게논 g 및 상게놀 a를 유효성분으로 함유하는 스트레스 또는 우울 증상의 개선, 예방 또는 치료용 조성물
TWI725317B (zh) 新穿心蓮內酯之組成物用於血糖調降之應用
Gupta et al. A miracle fruit plant-Gymnema sylvestre R. Br.(Retz)
JP7228544B2 (ja) 有効成分としてヤブラン（Ｌｉｒｉｏｐｅ ｐｌａｔｙｐｈｙｌｌａ）の抽出物を含む、ニコチン中毒の予防又は治療用の組成物
TWI538684B (zh) 具有護眼功能之中藥材組成物及其製造方法
JP7688733B2 (ja) 蒸し生姜抽出物又はこれから分離された１－デヒドロ－６－ジンジャージオンを有効成分として含む変形性関節症の予防、改善又は治療用組成物
JP2006151838A (ja) 糖質消化酵素阻害剤
KR100894029B1 (ko) 인삼 꽃을 원료로 하는 당뇨의 예방을 위한 약학 조성물 및 치료를 위한 약학 조성물
KR20190126565A (ko) 한약재 지용성 분획 추출물을 함유하는 통증의 개선, 예방 또는 치료용 조성물
KR100657018B1 (ko) 알코올성 간섬유화 예방 및 치료용 식물 유래 추출물
KR20240081878A (ko) 산사나무 뿌리 추출물을 유효성분으로 포함하는 비만의 예방 또는 치료용 약학적 조성물